Analysts are nudging up targets across financials, pharma, and industrials today — while trimming price expectations on GEV and DOV.
Robinhood Markets sees the biggest buzz. Consensus target price rose to $116.09, up from $114.97. The trading platform carries a $90 billion market cap. Short interest sits at just 5.1% of free float. Bulls have room to run.
Eli Lilly attracted fresh upward revisions. The average analyst target is now $1,243 — up from $1,240. 22 out of 28 analysts rate it a Buy. The pharma giant shows no signs of losing favour on the Street.
Trane Technologies also picked up a target lift to $522.94 from $522.61. The HVAC maker's consensus remains firmly bullish with 13 Buy ratings. Short sellers show little interest at just 2.1% of free float.
On the flip side, GE Vernova saw a small target trim to $1,221.48 from $1,222.63. The energy equipment giant still commands 29 Buy ratings. The target cut is minor. The bull case remains intact.
BlackRock and Ameriprise Financial both received upward target revisions. Financial sector sentiment is broadly improving as rate uncertainty fades.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
